Fresenius Medical Care AG & Co. KGaA (FME) Given Average Recommendation of “Buy” by Brokerages

Share on StockTwits

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a consensus rating of “Buy” by the nineteen ratings firms that are covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is €83.06 ($96.58).

FME has been the topic of several recent research reports. Deutsche Bank set a €100.00 ($116.28) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, April 9th. Goldman Sachs Group set a €79.00 ($91.86) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Monday, April 1st. Barclays set a €68.00 ($79.07) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Tuesday, January 15th. Berenberg Bank set a €88.85 ($103.31) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, February 5th. Finally, HSBC set a €87.00 ($101.16) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Tuesday, March 12th.

ETR:FME traded up €0.30 ($0.35) during mid-day trading on Thursday, hitting €75.26 ($87.51). The stock had a trading volume of 1,037,724 shares, compared to its average volume of 704,197. The company has a market cap of $22.87 billion and a PE ratio of 11.67. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €55.44 ($64.47) and a 52 week high of €91.74 ($106.67). The company has a quick ratio of 0.96, a current ratio of 1.25 and a debt-to-equity ratio of 58.49.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: What strategies should day traders use to execute a trade?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

AT&T Inc.  Shares Sold by VERITY Wealth Advisors
AT&T Inc. Shares Sold by VERITY Wealth Advisors
10,920 Shares in Preferred Apartment Communities Inc.  Purchased by Wedbush Securities Inc.
10,920 Shares in Preferred Apartment Communities Inc. Purchased by Wedbush Securities Inc.
Wedbush Securities Inc. Invests $193,000 in Kimco Realty Corp
Wedbush Securities Inc. Invests $193,000 in Kimco Realty Corp
Wedbush Securities Inc. Invests $205,000 in Hannon Armstrong Sustnbl Infrstr Cap Inc
Wedbush Securities Inc. Invests $205,000 in Hannon Armstrong Sustnbl Infrstr Cap Inc
Wedbush Securities Inc. Takes $212,000 Position in E*TRADE Financial Corp
Wedbush Securities Inc. Takes $212,000 Position in E*TRADE Financial Corp
Wedbush Securities Inc. Lowers Position in Canadian Pacific Railway Ltd
Wedbush Securities Inc. Lowers Position in Canadian Pacific Railway Ltd


 
© 2006-2019 Zolmax.